{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:34:39Z","timestamp":1762101279534},"reference-count":95,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1053\/j.ackd.2012.02.015","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T19:32:34Z","timestamp":1332531154000},"page":"84-92","source":"Crossref","is-referenced-by-count":22,"title":["Complement in Glomerular Disease"],"prefix":"10.1053","volume":"19","author":[{"given":"Katherine A.","family":"Vernon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Terence","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ackd.2012.02.015_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2012.02.015_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1042\/CS20020362","article-title":"Beyond lysis: how complement influences cell fate","volume":"104","author":"Cole","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1053\/j.ackd.2012.02.015_bib3","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1084\/jem.157.6.2029","article-title":"Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments","volume":"157","author":"Wetsel","year":"1983","journal-title":"J Exp Med"},{"key":"10.1053\/j.ackd.2012.02.015_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat Med"},{"key":"10.1053\/j.ackd.2012.02.015_bib5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1046\/j.1538-7836.2003.00306.x","article-title":"Thrombomodulin","volume":"1","author":"Weiler","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.ackd.2012.02.015_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1348-0421.2002.tb02669.x","article-title":"Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N","volume":"46","author":"Campbell","year":"2002","journal-title":"Microbiol Immunol"},{"key":"10.1053\/j.ackd.2012.02.015_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2012.02.015_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1078\/0171-2985-00141","article-title":"C1q, autoimmunity and apoptosis","volume":"205","author":"Botto","year":"2002","journal-title":"Immunobiology"},{"key":"10.1053\/j.ackd.2012.02.015_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.immunol.22.012703.104549","article-title":"The role of complement in the development of systemic lupus erythematosus","volume":"22","author":"Manderson","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/j.ackd.2012.02.015_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0598-56","article-title":"Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies","volume":"19","author":"Botto","year":"1998","journal-title":"Nat Genet"},{"key":"10.1053\/j.ackd.2012.02.015_bib11","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.4049\/jimmunol.166.11.6820","article-title":"Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice","volume":"166","author":"Robson","year":"2001","journal-title":"J Immunol"},{"key":"10.1053\/j.ackd.2012.02.015_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/rheumatology\/keh417","article-title":"A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus","volume":"44","author":"Seelen","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.ackd.2012.02.015_bib13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1172\/JCI200421075","article-title":"Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes","volume":"114","author":"Trouw","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2012.02.015_bib14","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/anr.1780321109","article-title":"Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity","volume":"32","author":"Kerr","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ackd.2012.02.015_bib15","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4049\/jimmunol.164.2.786","article-title":"Modulation of renal disease in MRL\/lpr mice genetically deficient in the alternative complement pathway factor B","volume":"164","author":"Watanabe","year":"2000","journal-title":"J Immunol"},{"key":"10.1053\/j.ackd.2012.02.015_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1523-1755.2004.00371.x","article-title":"Effects of complement factor D deficiency on the renal disease of MRL\/lpr mice","volume":"65","author":"Elliott","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2012.02.015_bib17","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.4049\/jimmunol.166.10.6444","article-title":"Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL\/lpr mice","volume":"166","author":"Sekine","year":"2001","journal-title":"J Immunol"},{"key":"10.1053\/j.ackd.2012.02.015_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2249.1997.4261438.x","article-title":"Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice","volume":"110","author":"Sheerin","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.ackd.2012.02.015_bib19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.it.2008.04.008","article-title":"Factor H family proteins and human diseases","volume":"29","author":"Jozsi","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1053\/j.ackd.2012.02.015_bib20","doi-asserted-by":"crossref","first-page":"e1002079","DOI":"10.1371\/journal.pgen.1002079","article-title":"Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility","volume":"7","author":"Zhao","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1053\/j.ackd.2012.02.015_bib21","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1093\/hmg\/ddq399","article-title":"An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD)","volume":"19","author":"Fritsche","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.ackd.2012.02.015_bib22","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/blood-2009-02-205641","article-title":"Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation","volume":"114","author":"Heinen","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.ackd.2012.02.015_bib23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.180.2.1231","article-title":"Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL\/lpr mice","volume":"180","author":"Atkinson","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1053\/j.ackd.2012.02.015_bib24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/rheumatology\/keh083","article-title":"Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody","volume":"43","author":"Ravirajan","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.ackd.2012.02.015_bib25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/ndt\/18.3.524","article-title":"Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis","volume":"18","author":"Neumann","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2012.02.015_bib26","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1053\/j.ajkd.2005.01.001","article-title":"Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs","volume":"45","author":"Schlieben","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2012.02.015_bib27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2012.02.015_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9440(10)62951-3","article-title":"The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies","volume":"167","author":"Xiao","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ackd.2012.02.015_bib29","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.4049\/jimmunol.158.9.4444","article-title":"Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils","volume":"158","author":"Wirthmueller","year":"1997","journal-title":"J Immunol"},{"key":"10.1053\/j.ackd.2012.02.015_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ackd.2012.02.015_bib30a","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000314775","article-title":"Experimental models of membranoproliferative glomerulonephritis, including dense deposit disease","volume":"169","author":"Vernon","year":"2011","journal-title":"Contrib Nephrol"},{"key":"10.1053\/j.ackd.2012.02.015_bib31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s10875-008-9268-2","article-title":"Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis","volume":"29","author":"Xing","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1053\/j.ackd.2012.02.015_bib32","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.ki.5002103","article-title":"Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice","volume":"71","author":"Huugen","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2012.02.015_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2012.02.015_bib34","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1172\/JCI112408","article-title":"Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy","volume":"77","author":"Cybulsky","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2012.02.015_bib35","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1046\/j.1523-1755.2003.00305.x","article-title":"Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy","volume":"64","author":"Saran","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2012.02.015_bib36","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy","volume":"364","author":"Stanescu","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2012.02.015_bib37","unstructured":"Ma H, Beck LH Jr, Salant DJ. Membranous nephropathy-associated anti-phospholipase A2 receptor IgG4 autoantibodies activate the lectin complement pathway. Oral presented at: American Society of Nephrology Kidney Week; November 8\u201313, 2011; Philadelphia, PA."},{"key":"10.1053\/j.ackd.2012.02.015_bib38","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1681\/ASN.2007030259","article-title":"Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy","volume":"18","author":"Giannakakis","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2012.02.015_bib39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000184350","article-title":"Composition of mesangial deposits in IgA nephropathy: complement factors","volume":"46","author":"Bene","year":"1987","journal-title":"Nephron"},{"key":"10.1053\/j.ackd.2012.02.015_bib40","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA activates the complement system via the mannan-binding lectin pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J Immunol"},{"key":"10.1053\/j.ackd.2012.02.015_bib41","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1681\/ASN.2005090923","article-title":"Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated\u00a0with more severe renal disease","volume":"17","author":"Roos","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2012.02.015_bib42","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/ndt\/gfn563","article-title":"Mesangial C4d deposition: a new prognostic factor in IgA nephropathy","volume":"24","author":"Espinosa","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2012.02.015_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng.787","article-title":"Genome-wide association study identifies susceptibility loci for IgA nephropathy","volume":"43","author":"Gharavi","year":"2011","journal-title":"Nat Genet"},{"key":"10.1053\/j.ackd.2012.02.015_bib44","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2012.02.015_bib45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0272-6386(87)80089-6","article-title":"Ultrastructural localization of the membrane attack complex of complement in human renal tissues","volume":"9","author":"Falk","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2012.02.015_bib46","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI116418","article-title":"Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells","volume":"91","author":"Halperin","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2012.02.015_bib47","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0272-6386(12)80440-9","article-title":"The extracellular matrix in diabetic nephropathy","volume":"22","author":"Ziyadeh","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2012.02.015_bib48","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1073\/pnas.97.10.5450","article-title":"Molecular basis for a link between complement and the vascular complications of diabetes","volume":"97","author":"Acosta","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ackd.2012.02.015_bib49","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2337\/diabetes.53.10.2653","article-title":"Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes","volume":"53","author":"Qin","year":"2004","journal-title":"Diabetes"},{"key":"10.1053\/j.ackd.2012.02.015_bib50","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.2337\/diabetes.48.7.1454","article-title":"Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study","volume":"48","author":"Orchard","year":"1999","journal-title":"Diabetes"},{"key":"10.1053\/j.ackd.2012.02.015_bib51","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrneph.2010.85","article-title":"C3\u00a0glomerulopathy: a new classification","volume":"6","author":"Fakhouri","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1053\/j.ackd.2012.02.015_bib52","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ki.1986.278","article-title":"H deficiency in two brothers with atypical dense intramembranous deposit disease","volume":"30","author":"Levy","year":"1986","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2012.02.015_bib53","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.163.8.4590","article-title":"Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H","volume":"163","author":"Jokiranta","year":"1999","journal-title":"J Immunol"},{"key":"10.1053\/j.ackd.2012.02.015_bib54","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.molimm.2010.02.002","article-title":"Anti-factor B autoantibody in dense deposit disease","volume":"47","author":"Strobel","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1053\/j.ackd.2012.02.015_bib55","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat Genet"},{"key":"10.1053\/j.ackd.2012.02.015_bib56","first-page":"608","article-title":"Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice","volume":"118","author":"Rose","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2012.02.015_bib57","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1172\/JCI43343","article-title":"Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation","volume":"120","author":"Martinez-Barricarte","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2012.02.015_bib58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jmg.2006.045328","article-title":"Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome","volume":"44","author":"Servais","year":"2007","journal-title":"J Med Genet"},{"key":"10.1053\/j.ackd.2012.02.015_bib59","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0090-1229(78)90160-5","article-title":"Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (Type I MPGN)","volume":"10","author":"Levy","year":"1978","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1053\/j.ackd.2012.02.015_bib60","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1097\/01.ASN.0000022006.49966.F8","article-title":"Linkage of a gene causing familial membranoproliferative glomerulonephritis type III to chromosome 1","volume":"13","author":"Neary","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2012.02.015_bib61","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1053\/ajkd.2002.33932","article-title":"Familial membranoproliferative glomerulonephritis type III","volume":"40","author":"Neary","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2012.02.015_bib62","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(10)60670-8","article-title":"Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis","volume":"376","author":"Gale","year":"2010","journal-title":"Lancet"},{"key":"10.1053\/j.ackd.2012.02.015_bib63","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/jmg.2005.038315","article-title":"Variations in the\u00a0complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)","volume":"43","author":"Abrera-Abeleda","year":"2006","journal-title":"J Med Genet"},{"key":"10.1053\/j.ackd.2012.02.015_bib64","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.2004100861","article-title":"Hemolytic uremic syndrome","volume":"16","author":"Noris","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2012.02.015_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/asheducation-2011.1.15","article-title":"Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations","volume":"2011","author":"Kavanagh","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1053\/j.ackd.2012.02.015_bib66","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.ackd.2012.02.015_bib67","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddi066","article-title":"Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32","volume":"14","author":"Esparza-Gordillo","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.ackd.2012.02.015_bib68","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fremeaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.ackd.2012.02.015_bib69","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.ackd.2012.02.015_bib70","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1681\/ASN.V122297","article-title":"The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20","volume":"12","author":"Caprioli","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2012.02.015_bib71","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J Med Genet"},{"key":"10.1053\/j.ackd.2012.02.015_bib72","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0140-6736(03)14742-3","article-title":"Familial haemolytic uraemic syndrome and an MCP mutation","volume":"362","author":"Noris","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.ackd.2012.02.015_bib73","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains","volume":"204","author":"Pickering","year":"2007","journal-title":"J Exp Med"},{"key":"10.1053\/j.ackd.2012.02.015_bib74","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1371\/journal.pmed.0030431","article-title":"Atypical haemolytic uraemic syndrome associated with a hybrid complement gene","volume":"3","author":"Venables","year":"2006","journal-title":"PLoS Med"},{"key":"10.1053\/j.ackd.2012.02.015_bib75","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2010050451","article-title":"The development of atypical hemolytic uremic syndrome depends on complement C5","volume":"22","author":"de Jorge","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2012.02.015_bib76","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1055\/s-0030-1262889","article-title":"New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab","volume":"36","author":"Kose","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.ackd.2012.02.015_bib77","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-associated HUS","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2012.02.015_bib78","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1523-1755.1998.00079.x","article-title":"The tubulointerstitium in progressive renal disease","volume":"54","author":"Nath","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2012.02.015_bib79","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1172\/JCI27699","article-title":"Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes","volume":"116","author":"Remuzzi","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.ackd.2012.02.015_bib80","first-page":"719","article-title":"Interstitial nephritis induced by protein-overload proteinuria","volume":"135","author":"Eddy","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ackd.2012.02.015_bib81","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/j.ackd.2012.02.015_bib82","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.ki.5002091","article-title":"Interaction between proximal tubular epithelial cells and infiltrating monocytes\/T cells in the proteinuric state","volume":"71","author":"Lai","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2012.02.015_bib83","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/ndt\/12.12.2562","article-title":"Urinary transforming growth factor-beta 1 in membranous glomerulonephritis","volume":"12","author":"Honkanen","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2012.02.015_bib84","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1681\/ASN.V114700","article-title":"Complement activation products in the urine from proteinuric patients","volume":"11","author":"Morita","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2012.02.015_bib85","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1749-6632.1983.tb22219.x","article-title":"The brush border of proximal tubules of normal human kidney activates the alternative pathway of the complement system in\u00a0vitro","volume":"420","author":"Camussi","year":"1983","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.ackd.2012.02.015_bib86","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ki.1994.247","article-title":"Localization of the complement regulatory proteins in the normal human kidney","volume":"46","author":"Ichida","year":"1994","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2012.02.015_bib87","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1681\/ASN.V10112323","article-title":"Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome","volume":"10","author":"Nangaku","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2012.02.015_bib88","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000189529","article-title":"Membrane attack complex and membrane cofactor protein are related to tubulointerstitial inflammation in various human glomerulopathies","volume":"75","author":"Mosolits","year":"1997","journal-title":"Nephron"},{"key":"10.1053\/j.ackd.2012.02.015_bib89","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/j.1523-1755.2004.00957.x","article-title":"C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis","volume":"66","author":"Rangan","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2012.02.015_bib90","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1523-1755.2000.00830.x","article-title":"Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy","volume":"57","author":"Mezzano","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2012.02.015_bib91","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ki.1986.28","article-title":"Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease","volume":"29","author":"Okuda","year":"1986","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2012.02.015_bib92","doi-asserted-by":"crossref","first-page":"F555","DOI":"10.1152\/ajprenal.00403.2006","article-title":"The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy","volume":"293","author":"Lenderink","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.ackd.2012.02.015_bib93","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.4049\/jimmunol.177.6.4094","article-title":"Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice","volume":"177","author":"Turnberg","year":"2006","journal-title":"J Immunol"},{"key":"10.1053\/j.ackd.2012.02.015_bib94","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1681\/ASN.2006121343","article-title":"Complement C5 mediates experimental tubulointerstitial fibrosis","volume":"18","author":"Boor","year":"2007","journal-title":"J Am Soc Nephrol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559512000547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559512000547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T23:04:15Z","timestamp":1713740655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559512000547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1548559512000547"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2012.02.015","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}